Eyenovia, a United States-based eye care firm, is making waves with an ambitious strategy involving cryptocurrency. The company is injecting $50 million into a new reserve plan anchored around HYPE, a digital token native to the Hyperliquid platform. With this daring move, Eyenovia grabs the spotlight as the first U.S.-listed firm to weave HYPE into its financial reserves.
Rather than relying on traditional assets like cash or bonds, Eyenovia has opted for a modern twist by backing its reserves with crypto. This marks a major shift in how public companies manage their balance sheets, signalling an embrace of the growing digital asset space. With this, the company is stepping outside the box and taking a route less travelled in corporate finance.
The funding for this strategy is coming from a private placement arrangement. By choosing this path, Eyenovia has secured capital directly from private investors rather than through open-market stock offerings. This allows the company to raise funds more swiftly and with fewer roadblocks.
Image 1: (Source: DeFi Planet)
Hyunsu Jung Takes the Reins
To steer this new direction, Eyenovia has named Hyunsu Jung as its Chief Investment Officer. He’s also taken a seat at the top table as part of the company’s board. Jung will oversee the management and strategic deployment of the HYPE holdings. His role is central to making sure the digital asset strategy supports the company’s long-term goals.
The decision to bring Jung on board reflects Eyenovia’s commitment to giving this crypto plan proper structure. His leadership will be vital as the company enters an area that’s still relatively fresh for most public corporations. With his expertise, Eyenovia is looking to make the most of this opportunity while keeping its operations running smoothly.
This isn’t a move made on a whim. It’s a calculated decision that aligns with Eyenovia’s broader vision of innovation—not just in healthcare but now in finance. The introduction of HYPE tokens into the treasury shows a willingness to break the mould and experiment with tools that might shape the future of corporate reserves.
Eyenovia, a publicly traded company, is buying $50M worth of HYPE and staking all of ithttps://t.co/lLmrEkM1bu
H/t @ericonomic pic.twitter.com/u6axCA9PEP
— MLM (@mlmabc) June 17, 2025
Strengthening the Core
Despite the excitement surrounding this new venture, Eyenovia is still focused on its core mission. The company remains committed to its medical platform, particularly its signature device, the Optejet. This technology offers a novel way of delivering medication to the eye, using a gentle mist instead of traditional drops.
The Optejet system is designed to improve how patients manage their treatment. By making the delivery process easier, Eyenovia aims to help users stay on course with their medication and potentially achieve better results. This solution not only supports patients but also assists healthcare providers in delivering more precise and consistent care.
Image 2: (Source: CoinJournal)
The innovation behind Optejet ties directly into Eyenovia’s values. Though the crypto pivot marks a bold new chapter, Eyenovia’s main focus remains its mission to reshape eye treatment delivery. This dual focus on treatment technology and treasury innovation puts Eyenovia in a unique position within the market.
The $50 million crypto reserve doesn’t detract from the company’s broader strategy. Instead, it complements its efforts by offering financial diversity and potential flexibility in managing its resources. It’s a way of keeping several irons in the fire while staying true to the company’s origins.
Also noted are matters linked to the development of Eyenovia’s products. These involve potential clinical trials and the commercial rollout of Optejet. Even as Eyenovia dips its toes into digital finance, its core focus still beats strong in the world of eye care innovation.
Read also: CFTC Paralysis Puts Crypto Regulation in Jeopardy Amid Leadership Void
Eyenovia’s blend of tradition and bold innovation might just prove to be the perfect recipe for the next chapter in its journey.
